Tag Archives: fungal meningitis outbreak

Featured Stories

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Exploding Tanks Kill Jeep Drivers 18 months after Recall

Exploding Gas Tanks Continue to Kill Jeep Drivers 18 months after Recall

Chrysler recalled Jeeps with exploding gas tanks more than 18 months ago, but 1 million+ of these vehicles have not been fixed as the death toll continues to rise.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

FDA lacked jurisdiction to enforce violations at NECC in the past, was slow to release inspection results

As the Food and Drug Administration aims to assert more authority in regulating drug compounding pharmacies like the one responsible for the deadly nationwide outbreak of fungal meningitis, details have emerged that the agency has previously tried to flex regulatory … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals | Tagged , , , |

Senators promise action to prevent the next fungal meningitis outbreak

Lawmakers on Capitol Hill have promised to update federal regulations, namely with the Food and Drug Administration, that would bring pharmaceutical drug compounding labs under the agency’s eye in the future in hopes of avoiding situations like the current deadly … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Product Recalls | Tagged , , |

Ameridose shares more than owners with embattled compounding center

Conditions at Ameridose, a Massachusetts-based pharmaceutical drug supplier that shares some of the same owners as the company tied to the deadly nationwide outbreak of fungal meningitis, are such that it can not guarantee the safety of any of the … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged , |

Main threat of fungal meningitis passes, health officials warn victims not yet in the clear

The primary threat posed by contaminated epidural steroid injection that’s been linked to a nationwide outbreak of fungal meningitis has passed but those who received the drugs are not in the clear just yet. According to an ABC News report, … Continue reading

Posted in Pharmaceuticals | Tagged |

Stress, worry plague those injected with contaminated steroid drug

For the thousands who received a contaminated epidural steroid injection in the last few months, the next few days and weeks will be filled with worry and stress as they wonder if they’ll be the next victims in the deadly … Continue reading

Posted in Pharmaceuticals | Tagged |

Variety of lawsuits filed in response to fungal meningitis outbreak

The victims of the deadly fungal meningitis outbreak have already begun to seek justice for their injuries or if they’ve lost a loved one who received a contaminated epidural steroid injection. According to a Reuters report, victims have two choices … Continue reading

Posted in Defective Products, Legal News, Malpractice, Pharmaceuticals | Tagged |

Conditions inside New England Compounding Center conducive to contamination

The drug compounding lab likely responsible for the deadly nationwide outbreak of fungal meningitis ignored many safety protocols designed to ensure sterility of its products. According to a New York Times report this week, health officials in Massachusetts released a … Continue reading

Posted in Pharmaceuticals | Tagged |

Skepticism of company at center of fungal meningitis outbreak continues to grow

The company at the center of the deadly fungal meningitis outbreak has been under increased oversight since a 2006 inspection of its pharmacy labs discovered widespread deficiencies in protocols for manufacturing drugs. According to an AP report, New England Compounding … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , |

Questions, concerns mount against New England Compounding Center as fungal meningitis outbreak widens

Health officials across the country fear that many of the other compounded or mixed drugs leaving the pharmacies at New England Compounding Center may be just as contaminated as the epidural steroid drug that has caused a deadly nationwide outbreak … Continue reading

Posted in Pharmaceuticals | Tagged |

More Floridians affected by fungal meningitis outbreak, third death in state reported

Health officials in Florida have confirmed a third death in the state linked to the nationwide outbreak of fungal meningitis. According to a WESH-TV report in Orlando, Fla., Florida’s Dept. of Health said Wednesday that a third person who received … Continue reading

Posted in Pharmaceuticals | Tagged |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.